12:00 AM
 | 
Nov 10, 2008
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

PolyMedix preclinical data

In vitro, PMX30016 had broad spectrum activity against drug-susceptible and drug-resistant strains of Candida. The arylamide...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >